Gain Therapeutics, Inc.
NASDAQGANX utilisation hits 95.92%, nearing the 52-week high of 100% as short interest climbs 8.4% in one day to 9.8% of float.
Snapshot as of 9 May 2026
No long-form analysis yet for GANX. Pulse alerts and the live data picture are available on ORTEX.
Open GANX on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for GANX — free to start on ORTEX.
Sign up for free →Open GANX on ORTEX